The Cigna Group’s Stock Price Plummets to $247.10, Recording a Staggering 17.39% Drop

The Cigna Group (CI)

247.10 USD -52.02 (-17.39%) Volume: 9.34M

The Cigna Group’s stock price currently stands at 247.10 USD, experiencing a significant drop of -17.39% this trading session with a high trading volume of 9.34M. The healthcare conglomerate’s year-to-date performance also shows a decrease, with a percentage change of -10.52%, indicating a challenging market scenario.

Latest developments on The Cigna Group

Cigna Group stock experienced a tumultuous day as it tumbled due to margin warnings for its Pharmacy Benefit Services, despite posting higher profits and revenues. The company’s decision to end drug rebates sparked questions about the impact on premiums, leading to concerns about margin pressure in the pharmacy benefit unit over the next two years. Despite beating earnings estimates and reaffirming its 2025 outlook with a nearly $2 billion profit in Q3, Cigna’s stock fell as investors reacted to the news. The transition to a rebate-free pharmacy model raised uncertainties about future profitability, causing shares to underperform compared to competitors. With lower premiums potentially affecting Q3 earnings, investors are closely monitoring Cigna’s strategic growth and financial trajectory amidst changing market dynamics.

The Cigna Group on Smartkarma

Analysts on Smartkarma, such as Baptista Research, are bullish on Cigna Group‘s future prospects. In a recent research report titled “Cigna Group: Broad Suite of GLP-1 Solutions to Innovate & Lead In Addressing Contemporary Healthcare Challenges Efficiently!”, they highlighted the company’s strong performance in the first quarter of 2025. Cigna reported total revenues of $65.5 billion and adjusted earnings per share of $6.74, prompting an increase in full-year EPS guidance to at least $29.60.

A look at The Cigna Group Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Cigna Group has a positive long-term outlook. With high scores in both value and dividend, investors can expect a solid return on their investment. While the growth score is slightly lower, the company’s resilience and momentum scores indicate stability and potential for future growth. Overall, Cigna Group seems well-positioned for success in the insurance industry.

The Cigna Group operates as an insurance company, offering a range of insurance products and services to individuals, families, and businesses globally. With strong scores in value and dividend, the company shows promise for investors looking for stable returns. Although the growth score is not as high, Cigna Group‘s resilience and momentum scores suggest a steady and reliable performance in the long term.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma